Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported) June 11, 2013

 

 

CME GROUP INC.

(Exact Name of Registrant as Specified in Charter)

 

 

 

Delaware   001-31553   36-4459170

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File No.)

 

(IRS Employer

Identification No.)

20 South Wacker Drive

Chicago, Illinois 60606

(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code: (312) 930-1000

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.07. Submission of Matters to a Vote of Security Holders.

CME Group Inc. (the “Company”) held its Annual Meeting on May 22, 2013 (the “Annual Meeting”). The results of the Annual Meeting were reported on a Current Report, filed with the SEC on May 28, 2013, and the Company disclosed that the election of five members of the Class B-2 Nominating Committee to serve until 2014 from a slate of ten nominees (elected by the Class B-2 shareholders) was deferred to June 11, 2013 at 1:30 p.m. at 20 South Wacker Drive, Chicago, Illinois. The following are the results from the deferred proposal:

The election of five members of the Class B-2 Nominating Committee to serve until 2014 from a slate of ten nominees (elected by the Class B-2 shareholders):

 

Name

   Votes For      Votes Against      Abstentions  

Justin R. Bouchard

     23         31         205   

Jeffrey R. Carter

     99         18         142   

Richard J. Duran

     90         12         157   

Yra G. Harris

     116         20         123   

Donald M. Karel

     47         30         182   

Donald J. Lanphere Jr.

     102         23         134   

Michael E. Lattner

     62         22         175   

Patrick J. Mulchrone

     134         11         114   

Gregory J. Veselica

     64         23         172   

Barry D. Ward

     64         25         170   


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

   

CME Group Inc.

Registrant

Date: June 13, 2013     By:   /s/ Kathleen M. Cronin
    Name:   Kathleen M. Cronin
    Title:   Senior Managing Director, General Counsel and Corporate Secretary